Loading clinical trials...

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis | Clinical Trials | Clareo Health

COMPLETEDNA

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Evaluation of Breathe-Easy Hayfever Care for Managing Symptoms in Patients With Seasonal Allergic Rhinitis

NCT06765239•Innowage Limited

Summary

This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Mild to moderate symptoms during the hayfever season
•Generally healthy individuals without chronic illnesses
•Willingness to comply with study requirements, including completing symptom diaries.

Exclusion Criteria

•History of anaphylaxis or severe hayfever symptoms requiring emergency treatment.
•Pregnant or breastfeeding
•History of substance abuse or excessive alcohol consumption.
•Use of systemic corticosteroids, immunotherapy

Locations (1)

Gyansanjeevani India

Jaipur, Rajasthan, India

Key Dates

Start Date

April 24, 2024

Primary Completion Date

June 6, 2024

Completion Date

June 15, 2024

Last Updated

January 9, 2025

Enrollment

ACTUAL participants

Conditions

HayfeverAllergy PollenAllergic Rhinitis

Interventions

Hayfever Care

DIETARY_SUPPLEMENT

Wait-list Control

OTHER

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

NCT06732414

Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

View study

RECRUITINGNA

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT05494346

Acute RhinitisNasal Obstruction+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Inclusion Criteria

Exclusion Criteria

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis